Clinical trials: HLA Sensitization
Kidney Transplantation, Immunosuppressive Agents
Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis
This study is an analytical observational retrospective cohort study. It is a single-center study conducted in the Nancy University Hospital. End stage renal disease is the ultimate stage of the chronic kidney disease.
- Conditions
- Kidney Transplantation, Immunosuppressive Agents, HLA Sensitization, Dialysis
- Trial name
- NCT05282875
- Testing
- management of immunosuppressive therapy
- Where
- France
- Volunteers
- 430 people
- Sponsor
- Central Hospital, Nancy, France
Bone Cancer
HLA Sensitization Following Major Cortical Allograft Bone Procedures
The purpose of this study is to find out whether or not antibodies to the donor bone are present in the blood of patients who receive the donor bone.
- Trial name
- NCT00160719
- Testing
- retrieve blood samples
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of Florida
HLA/AAV Sensitization, Auto-immune Diseases
Real-world Clinical Effectiveness & Safety LV009, an in Vivo CAR-T for the Treatment of Hematologic Cancers, Auto-immune Diseases & HLA/ AAV Sensitization.
The study objective is to determine the real-world safety and effectiveness of LV009 therapy for 3 potential indications: (1) refractory or relapsed hematologic cancers (acute lymphoblastic Leukemia, B cell Lymphomas, multiple…
- Conditions
- HLA/AAV Sensitization, Auto-immune Diseases, Hematologic Cancers
- Trial name
- LV009 (NCT07873476)
- Testing
- LV009
- Where
- Indonesia
- Volunteers
- 100 people
- Sponsor
- Healthy Malaysia Association